Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2025 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungen
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to The Report
Fundraising

ThreatLocker

ThreatLocker Raises $115M in Series A

2017
Founded
600+
Employees
340 Royal Poinciana Way, Palm Beach, FL 33480
Updated May 14, 2024
2 min read

Quick Facts

ThreatLocker Raises $115M in Series A


ThreatLocker has successfully raised $115M in a Series A at a $500M valuation led by General Atlantic, Elephant Partners.


Company Overview


ThreatLocker is a Cybersecurity company headquartered in 340 Royal Poinciana Way, Palm Beach, FL 33480, founded in 2017 with 600+ employees.


Zero trust endpoint security


Fundraising Details


  • Amount Raised: $115M
  • Round Type: Series A
  • Valuation: $500M
  • Date: 2024-05-14
  • Investors: General Atlantic, Elephant Partners

About ThreatLocker


Zero trust endpoint security The company is positioned in the Cybersecurity sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 340 Royal Poinciana Way, Palm Beach, FL 33480
  • Founded: 2017
  • Team Size: 600+
  • Industry: Cybersecurity

What This Means


This funding round demonstrates strong investor confidence in ThreatLocker's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Cybersecurity sector continues to attract significant investment as companies innovate to meet evolving market demands. ThreatLocker's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $500M valuation marks an important milestone for ThreatLocker, positioning the company among notable players in the Cybersecurity industry.


Looking Ahead


With this new capital, ThreatLocker is well-positioned to execute on its growth strategy and continue building innovative solutions in the Cybersecurity space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-05-14. For more information about ThreatLocker, visit their headquarters at 340 Royal Poinciana Way, Palm Beach, FL 33480.

Topics

Fundraising(2912)Cybersecurity(452)Series AThreatLocker

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million